Advancing immunotherapy in triple negative breast Cancer: A novel multimodal theranostic nanoplatform integrating synergetic ferroptosis and photothermal therapy.

MLA

Cheng, Long, et al. “Advancing Immunotherapy in Triple Negative Breast Cancer: A Novel Multimodal Theranostic Nanoplatform Integrating Synergetic Ferroptosis and Photothermal Therapy.” Chemical Engineering Journal, vol. 485, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cej.2024.150057.

APA

Cheng, L., Qiu, Y., He, L., Wang, H., Zheng, M., Wang, R., Hu, Y., Yu, H., Luo, W., Xia, Y., Cao, Y., Wang, Z., Wang, Y., Ran, H., & Yang, L. (2024). Advancing immunotherapy in triple negative breast Cancer: A novel multimodal theranostic nanoplatform integrating synergetic ferroptosis and photothermal therapy. Chemical Engineering Journal, 485, N.PAG. https://doi.org/10.1016/j.cej.2024.150057

Chicago

Cheng, Long, Yibo Qiu, Lingyun He, Haiyang Wang, Min Zheng, Ruoyao Wang, Yaqin Hu, et al. 2024. “Advancing Immunotherapy in Triple Negative Breast Cancer: A Novel Multimodal Theranostic Nanoplatform Integrating Synergetic Ferroptosis and Photothermal Therapy.” Chemical Engineering Journal 485 (April): N.PAG. doi:10.1016/j.cej.2024.150057.